Mario Scuri
About
Mario Scuri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services.
According to data from OpenAlex, Mario Scuri has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 27 papers in Physiology and 5 papers in Emergency Medical Services. Recurrent topics in Mario Scuri's work include Asthma and respiratory diseases (26 papers), Inhalation and Respiratory Drug Delivery (21 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers). Mario Scuri is often cited by papers focused on Asthma and respiratory diseases (26 papers), Inhalation and Respiratory Drug Delivery (21 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers). Mario Scuri collaborates with scholars based in Italy, United Kingdom and United States. Mario Scuri's co-authors include Stefano Vezzoli, Dave Singh, Alberto Papi, Jørgen Vestbo, Massimo Corradi, Isabella Montagna, Géraldine Cohuet, William M. Abraham, Catherine Francisco and Stefano Petruzzelli and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.
In The Last Decade
Mario Scuri
49 papers receiving 1.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mario Scuri Italy | 19 | 1.3k | 1.1k | 176 | 136 | 83 | 53 | 1.8k | ||
| Céline Bergeron Canada | 23 | 711 0.5× | 1.1k 1.0× | 366 2.1× | 239 1.8× | 22 0.3× | 51 | 2.0k | ||
| P.W. Ind United Kingdom | 16 | 1.1k 0.8× | 1.3k 1.2× | 189 1.1× | 177 1.3× | 25 0.3× | 33 | 1.8k | ||
| Carol A. Tozzi United States | 22 | 975 0.7× | 783 0.7× | 74 0.4× | 153 1.1× | 195 2.3× | 44 | 1.6k | ||
| Merritt L. Fajt United States | 15 | 617 0.5× | 1.1k 1.0× | 516 2.9× | 112 0.8× | 21 0.3× | 53 | 1.4k | ||
| A E Redington United Kingdom | 17 | 829 0.6× | 1.4k 1.2× | 458 2.6× | 157 1.2× | 145 1.7× | 25 | 2.0k | ||
| L. DuBuske United States | 19 | 305 0.2× | 817 0.7× | 171 1.0× | 134 1.0× | 48 0.6× | 164 | 1.5k | ||
| Againdra K. Bewtra United States | 24 | 968 0.7× | 1.4k 1.2× | 378 2.1× | 270 2.0× | 42 0.5× | 94 | 2.4k | ||
| C M Lilly United States | 18 | 546 0.4× | 1.1k 1.0× | 357 2.0× | 201 1.5× | 56 0.7× | 26 | 1.7k | ||
| R. Testi Italy | 18 | 851 0.6× | 957 0.8× | 102 0.6× | 108 0.8× | 15 0.2× | 35 | 1.3k | ||
| R. Grönneberg Sweden | 24 | 296 0.2× | 958 0.8× | 321 1.8× | 223 1.6× | 23 0.3× | 60 | 1.7k |
Countries citing papers authored by Mario Scuri
Since
Specialization
Citations
This map shows the geographic impact of Mario Scuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Scuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Scuri more than expected).
Fields of papers citing papers by Mario Scuri
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mario Scuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Scuri. The network helps show where Mario Scuri may publish in the future.
Co-authorship network of co-authors of Mario Scuri
This figure shows the co-authorship network connecting the top 25 collaborators of Mario Scuri. A scholar is included among the top collaborators of Mario Scuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Scuri. Mario Scuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chetta, Alfredo, et al.. (2021). Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD. BMC Pulmonary Medicine. 21(1). 65–65.
2.
Papi, Alberto, Jørgen Vestbo, Leonardo M. Fabbri, et al.. (2018). Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. The Lancet. 391(10125). 1076–1084.
3.
Vestbo, Jørgen, Alberto Papi, Massimo Corradi, et al.. (2017). Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial. The Lancet. 389(10082). 1919–1929.
4.
Singh, Dave, et al.. (2017). Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study. International Journal of COPD. Volume 12. 2001–2014.
5.
Singh, Dave, Alberto Papi, Massimo Corradi, et al.. (2016). Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet. 388(10048). 963–973.
6.
Crisafulli, Ernesto, Andrea Zanini, Giovanna Pisi, et al.. (2016). Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma. Expert Review of Respiratory Medicine. 10(5). 481–490.
7.
Corradi, Massimo, Manuela Latorre, Christian Geßner, et al.. (2016). High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids. BMC Pulmonary Medicine. 16(1). 180–180.
8.
Paggiaro, Pierluigi, Massimo Corradi, Roberta Baronio, et al.. (2014). High dose extrafine beclomethasone/formoterol via metered dose inhaler is effective and safe in asthmatics not controlled on medium-high dose of inhaled corticosteroids. European Respiratory Journal. 44(Suppl 58). P901–P901.
9.
Kanniess, Frank, Mario Scuri, Stefano Vezzoli, Catherine Francisco, & Stefano Petruzzelli. (2014). Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler®) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial. Pulmonary Pharmacology & Therapeutics. 30. 121–127.
10.
Voshaar, Thomas, et al.. (2013). Comparing Usability of NEXThaler ® with Other Inhaled Corticosteroid/Long-Acting β 2 -Agonist Fixed Combination Dry Powder Inhalers in Asthma Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(5). 363–370.
11.
Scuri, Mario, Bean T. Chen, Vincent Castranova, et al.. (2010). Effects of Titanium Dioxide Nanoparticle Exposure on Neuroimmune Responses in Rat Airways. Journal of Toxicology and Environmental Health. 73(20). 1353–1369.
12.
Scuri, Mario, Juan Sabater, & William M. Abraham. (2007). Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep. Journal of Applied Physiology. 102(6). 2324–2331.
13.
Abraham, William M., Mario Scuri, & Stephen G. Farmer. (2006). Peptide and non-peptide bradykinin receptor antagonists: Role in allergic airway disease. European Journal of Pharmacology. 533(1-3). 215–221.
14.
Senni, Michele, Renata De Maria, Carlo Berzuini, et al.. (2006). A Novel Prognostic Index to Determine the Impact of Cardiac Conditions and Co-Morbidities on One-Year Outcome in Patients With Heart Failure. The American Journal of Cardiology. 98(8). 1076–1082.
15.
Scuri, Mario, et al.. (2001). Hyaluronic Acid Blocks Porcine Pancreatic Elastase (PPE)-induced Bronchoconstriction in Sheep. American Journal of Respiratory and Critical Care Medicine. 164(10). 1855–1859.
16.
Sabater, Juan, Mario Scuri, Richard Coffey, et al.. (2000). The Lactoperoxidase System Functions in Bacterial Clearance of Airways. American Journal of Respiratory Cell and Molecular Biology. 22(6). 665–671.
17.
Scuri, Mario, L. Allegra, & William M. Abraham. (1998). The Effects of Multiple Dosing with Zileuton on Antigen-Induced Responses in Sheep. Pulmonary Pharmacology & Therapeutics. 11(4). 277–280.
18.
Scuri, Mario. (1997). Connective tissue growth factor stimulates proliferation of human lung fibroblasts. American Journal of Respiratory and Critical Care Medicine. 155.
19.
Scuri, Mario, et al.. (1996). Inhaled Tryptase Causes Bronchoconstriction in Sheep via Histamine Release. American Journal of Respiratory and Critical Care Medicine. 154(3). 649–653.
20.
Bianco, S., M. Robuschi, Mario Scuri, et al.. (1993). Efficacy and Tolerability of Nimesulide in Asthmatic Patients Intolerant to Aspirin. Drugs. 46(Supplement 1). 115–120.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Céline Bergeron Breakdown of academic impact, for papers by P.W. Ind Breakdown of academic impact, for papers by Carol A. Tozzi Breakdown of academic impact, for papers by Merritt L. Fajt Breakdown of academic impact, for papers by A E Redington Breakdown of academic impact, for papers by L. DuBuske Breakdown of academic impact, for papers by Againdra K. Bewtra Breakdown of academic impact, for papers by C M Lilly Breakdown of academic impact, for papers by R. Testi Breakdown of academic impact, for papers by R. Grönneberg